Universidad Complutense de Madrid
E-Prints Complutense

Glaukos iStent inject® Trabecular Micro-Bypass Implantation Associated with Cataract Surgery in Patients with Coexisting Cataract and Open-Angle Glaucoma or Ocular Hypertension: A Long-Term Study

Impacto

Descargas

Último año

Arriola Villalobos, Pedro y Martínez de la Casa, Jose Maria y Díaz Valle, David y Morales Fernández, Laura y Fernández Pérez, Cristina y García Feijoo, Julián (2016) Glaukos iStent inject® Trabecular Micro-Bypass Implantation Associated with Cataract Surgery in Patients with Coexisting Cataract and Open-Angle Glaucoma or Ocular Hypertension: A Long-Term Study. Journal of Ophthalmology, 2016 . 7 p.. ISSN 2090-004X

[img]
Vista previa
PDF
Creative Commons License
Esta obra está bajo una licencia de Creative Commons: Reconocimiento - No comercial.

1MB

URL Oficial: http://dx.doi.org/10.1155/2016/1056573




Resumen

Purpose. To evaluate the long-term efficacy and safety of the iStent inject device (Glaukos Corporation, Laguna Hills, CA) combined with phacoemulsification in patients with coexistent cataract and open-angle glaucoma or ocular hypertension (OHT). Methods. A prospective, uncontrolled, nonrandomized, interventional case series study was conducted in patients with both mild or moderate open-angle glaucoma or OHT and cataract. Patients underwent cataract surgery along with the implant of two iStent inject devices. Outcome measures were intraocular pressure (IOP), topical hypotensive medications required, and best-corrected visual acuity (BCVA). Results. 20 patients were enrolled. Mean follow-up was months. Mean baseline IOP was  mmHg with medication and  mmHg after washout. Mean end-follow-up IOP was  mmHg, representing an IOP decrease of 36.92%,  mmHg (), from baseline washout IOP. The mean number of medications was significantly reduced from to (). 45% of patients were medication-free by the end of follow-up. Mean BCVA improved significantly from to (). No complications of surgery were observed. Conclusion. The iStent inject device combined with cataract surgery served to significantly reduce both IOP and medication use in the long term in patients with coexistent open-angle glaucoma or ocular hypertension (OHT) and cataract.


Tipo de documento:Artículo
Información Adicional:

Received 17 June 2016; Revised 9 September 2016; Accepted 5 October 2016

Palabras clave:Trabecular Micro-bypass implantation ; Cataract surgery ; Open-angle glaucoma ; Ocular hypertension
Materias:Ciencias Biomédicas > Medicina > Cirugía
Ciencias Biomédicas > Medicina > Oftalmología
Ciencias Biomédicas > Óptica y optometría > Óptica oftálmica
Código ID:44479
Depositado:14 Sep 2017 12:33
Última Modificación:14 Sep 2017 12:33

Descargas en el último año

Sólo personal del repositorio: página de control del artículo